secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2026-03-04T23:59:59+00:00
Accession:  0001493152-26-008897
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology closes $30M public offering of 20M shares at $1.50/sh
------------------------------------------------------------------------

- Closed underwritten public offering of 20M shares at $1.50/sh, gross proceeds $30M.
- Underwriters granted 30-day option to buy up to 3M additional shares for over-allotments.
- Net proceeds to fund clinical trials and working capital; offering closed March 4, 2026.
- Konik Capital Partners acted as sole book-running manager; 60-day lock-up for insiders.
- Offering structured as common stock only with no warrant coverage; led by healthcare investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000149315226008897/0001493152-26-008897-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000149315226008897/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008897

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer